{"Exaggerate": "The claim may be seen as exaggerating the decrease in premiums on Medicare's prescription drug program, as the expert's investigation found that the \"base beneficiary premium\" actually increased almost every year.", "Lack enough support": "The claim lacks sufficient evidence or support to prove that the premiums on Medicare's prescription drug program have fallen almost every year since it began.", "Problematic assumption": "The claim assumes that the decrease in premiums is solely due to competition, without considering other factors that may have influenced the changes in premiums.", "Exist alternative explanation": "The claim does not address whether competition caused changes in the program's premiums, leaving room for alternative explanations for the observed trends."}